COLL — Collegium Pharmaceutical Share News
0.000.00%
Last trade - 00:00- $765.06m
- $1.85bn
- $780.57m
Collegium Pharmaceutical Inc expected to post earnings of 90 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Hub Group, Varonis Systems, WEX
U.S. RESEARCH ROUNDUP- Acuity Brands, Bluebird Bio, Imara
Brief: Collegium Pharmaceutical Executes Master Settlement Agreement Resolving All 27 Pending Opioid-Related Lawsuits Brought Against Co
U.S. RESEARCH ROUNDUP-Biodelivery Sciences International, Foot Locker, Universal Health Services
U.S. RESEARCH ROUNDUP-Beigene, Foot Locker, Universal Health Services
Collegium Pharmaceutical Inc reports results for the quarter ended in December - Earnings Summary
Brief: Collegium Reports Q4 And Full-Year 2021 Financial Results
Collegium Pharmaceutical Inc expected to post earnings of $1.04 a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Life Storage, Novavax, Ritchie Bros Auctioneers
Brief: Biodelivery Sciences International Inc - Will Be Required To Pay Collegium Termination Fee Of An Amount In Cash Equal To About $18.1 Million
Brief: Biopharma Credit Plc To Invest $325 Mln In Collegium Pharma Inc
Brief: Collegium To Acquire Biodelivery Sciences In An All-Cash Deal
BioDelivery surges on Collegium's $604 mln acquisition
Brief: Collegium Announces Settlement Framework To Resolve Pending Opioid-Related Litigation
Collegium rises on share buyback plan
Brief: Collegium Announces $25 Million Accelerated Share Repurchase Program
Brief: Collegium Pharmaceutical Announced Headcount Reduction By About 20%
Collegium Pharmaceutical Inc reports results for the quarter ended in September - Earnings Summary